Department of Radiotherapy, Changzhou Tumor Hospital, Soochow University, Changzhou, People's Republic of China.
Department of Molecular Radiobiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Onco Targets Ther. 2014 Sep 26;7:1753-9. doi: 10.2147/OTT.S66667. eCollection 2014.
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers worldwide. Yin Yang 1 (YY1) is a ubiquitous and multifunctional zinc-finger transcription factor that plays important biological functions in cell homeostasis and tumorigenesis. The purpose of this study was to investigate the expression of YY1 in different ESCC tissues and the potential relationship with clinicopathological features.
One hundred and four ESCC tissues were collected in this study. The protein levels of YY1 were measured by immunohistochemistry. TE-1 cell invasion in vitro was assessed using the Transwell assay.
There were no obvious differences between expression levels in patients over age 64 and those younger than 64, and no noticeable distinction was observed between males and females. However, the YY1 protein level was significantly higher in ESCC tissues with lymph node metastasis than those without lymph node metastasis (P=0.042). Furthermore, the expression of the YY1 protein was stronger in stage III-IV patients than in stage I-II patients (P=0.002), but the protein levels between different histological grades (well, moderate, or poor) showed no statistical significance. Similarly, there was no difference in YY1 expression in patients with or without lymphatic invasion. The Transwell assay revealed that the overexpression of YY1 promoted the invasion ability of TE-1 cells and the inhibition of YY1 could reverse this promotion.
YY1 expression was associated with TNM stage and lymph node metastasis, suggesting that YY1 can influence human esophageal cancer progression and metastasis.
食管鳞状细胞癌(ESCC)是全球最致命的癌症之一。Yin Yang 1(YY1)是一种普遍存在且多功能的锌指转录因子,在细胞内稳态和肿瘤发生中发挥着重要的生物学功能。本研究旨在探讨 YY1 在不同 ESCC 组织中的表达情况及其与临床病理特征的潜在关系。
本研究共收集了 104 例 ESCC 组织。采用免疫组织化学法检测 YY1 蛋白的表达水平。通过 Transwell 实验评估 TE-1 细胞的体外侵袭能力。
在年龄大于 64 岁和小于 64 岁的患者之间,以及在男性和女性患者之间,YY1 蛋白的表达水平没有明显差异。然而,有淋巴结转移的 ESCC 组织中 YY1 蛋白的表达水平明显高于无淋巴结转移的组织(P=0.042)。此外,YY1 蛋白的表达在 III-IV 期患者中明显高于 I-II 期患者(P=0.002),但在不同组织学分级(高、中、低)之间的表达水平没有统计学意义。同样,在有或无淋巴侵犯的患者中,YY1 的表达水平没有差异。Transwell 实验表明,YY1 的过表达促进了 TE-1 细胞的侵袭能力,而 YY1 的抑制作用可以逆转这种促进作用。
YY1 的表达与 TNM 分期和淋巴结转移有关,表明 YY1 可以影响人类食管癌细胞的进展和转移。